• 1
    Hansson GK,Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 50819.
  • 2
    Lusis AJ. Atherosclerosis. Nature 2000; 407: 233241.
  • 3
    van Gils JM,Zwaginga JJ,Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009; 85: 195204.
  • 4
    Vorchheimer DA,Becker R. Platelets in atherothrombosis. Mayo Clin Proc 2006; 81: 5968.
  • 5
    Bombeli T,Schwartz BR,Harlan JM. Adhesion of activated platelets to endothelial cells: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998; 187: 329339.
  • 6
    Burger PC,Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 26612666.
  • 7
    Frenette PS,Johnson RC,Hynes RO,Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 74507454.
  • 8
    Gawaz M,Konrad I,Hauser AI,Sauer S,Li Z,Wester HJ,Bengel FM,Schwaiger M,Schomig A,Massberg S,Haubner R. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions. Thromb Haemost 2005; 93: 910913.
  • 9
    Larsen E,Palabrica T,Sajer S,Gilbert GE,Wagner DD,Furie BC,Furie B. PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate. LNF III (CD15). Cell 1990; 63: 467474.
  • 10
    Huo Y,Schober A,Forlow SB,Smith DF,Hyman MC,Jung S,Littman DR,Weber C,Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 6167.
  • 11
    Macey MG,Wolf SI,Wheeler-Jones CP,Lawson C Expression of blood coagulation factors on monocytes after exposure to TNF-treated endothelium in a novel whole blood model of arterial flow. J Immunol Methods 2009; 350: 133141.
  • 12
    Rao LV,Pendurthi UR. Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol 2005; 25: 4756.
  • 13
    Szotowski B,Antoniak S,Poller W,Schultheiss HP,Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96: 12331239.
  • 14
    Panes O,Matus V,Saez CG,Quiroga T,Pereira J,Mezzano D. Human platelets synthesize and express functional tissue factor. Blood 2007; 109: 52425250.
  • 15
    Gomez K,McVey JH. Tissue factor initiated blood coagulation. Front Biosci 2006; 11: 13491359.
  • 16
    Grabowski EF,Reininger AJ,Petteruti PG,Tsukurov O,Orkin RW. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2001; 21: 157162.
  • 17
    Lwaleed BA,Bass PS. Tissue factor pathway inhibitor: Structure, biology and involvement in disease. J Pathol 2006; 208: 327339.
  • 18
    Asada Y,Hara S,Tsuneyoshi A,Hatakeyama K,Kisanuki A,Marutsuka K,Sato Y,Kamikubo Y,Sumiyoshi A. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta. Thromb Haemost 1998; 80: 506511.
  • 19
    Asada Y,Marutsuka K,Hatakeyama K,Sato Y,Hara S,Kisanuki A,Sumiyoshi A. The role of tissue factor in the pathogenesis of thrombosis and atherosclerosis. J Atheroscler Thromb 1998; 4: 135139.
  • 20
    Hatakeyama K,Asada Y,Marutsuka K,Kataoka H,Sato Y,Sumiyoshi A. Expression of tissue factor in the rabbit aorta after balloon injury. Atherosclerosis 1998; 139: 265271.
  • 21
    Hatakeyama K,Asada Y,Marutsuka K,Sato Y,Kamikubo Y,Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997; 133: 213219.
  • 22
    Sato Y,Asada Y,Marutsuka K,Hatakeyama K,Kamikubo Y,Sumiyoshi A. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Haemost 1997; 78: 11381141.
  • 23
    Chironi GN,Boulanger CM,Simon A,Dignat-George F,Freyssinet JM,Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335: 143151.
  • 24
    Halicka HD,Bedner E,Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res 2000; 260: 248256.
  • 25
    Essayagh S,Xuereb JM,Terrisse AD,Tellier-Cirioni L,Pipy B,Sie P. Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism. Thromb Haemost 2007; 98: 831837.
  • 26
    Piccin A,Murphy WG,Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157171.
  • 27
    Johansson U,Lawson C,Dabare M,Syndercombe-Court D,Newland AC,Howells GL,Macey MG. Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6. IL-8, and IL-1{beta}. J Leukoc Biol 2005; 78: 967975.
  • 28
    Lawson C,Ainsworth M,Yacoub M,Rose M. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism. J Immunol 1999; 162: 29902996.
  • 29
    Frangos JA,Eskin SG,McIntire LV,Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985; 227: 14771479.
  • 30
    Macey M,McCarthy D,Azam U,Milne T,Golledge P,Newland A Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): A novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood. Cytometry B Clin Cytom 2003; 51B: 3040.
  • 31
    McCarthy DA,Macey MG,Allen PD. A simple, novel, procedure for monitoring membrane scrambling and permeability in microparticles, platelets, and leukocytes in whole blood samples. Exp Hematol 2008; 36: 909921.
  • 32
    Holme PA,Orvim U,Hamers MJ,Solum NO,Brosstad FR,Barstad RM,Sakariassen KS. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17: 646653.
  • 33
    Nomura S,Tandon NN,Nakamura T,Kambayashi J. Morphological differences between GPIb antibody-induced and shear stress-induced platelet aggregates. Haemostasis 2000; 30: 174188.
  • 34
    Sakariassen KS,Holme PA,Orvim U,Barstad RM,Solum NO,Brosstad FR Shear-induced platelet activation and platelet microparticle formation in native human blood. Thromb Res 1998; 92(6 Suppl 2 ): S33S41.
  • 35
    Eccles KA,Sowden H,Porter KE,Parkin SM,Homer-Vanniasinkam S,Graham AM. Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Atherosclerosis 2008; 200: 6979.
  • 36
    Morel O,Toti F,Morel N,Freyssinet JM. Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Haematologica 2009; 94: 313317.
  • 37
    Huisse MG,Ajzenberg N,Feldman L,Guillin MC,Steg PG. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction. Thromb Haemost 2009; 101: 734740.
  • 38
    Morel O,Pereira B,Averous G,Faure A,Jesel L,Germain P,Grunebaum L,Ohlmann P,Freyssinet JM,Bareiss P,Toti F. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: Role of endothelial damage and leukocyte activation. Atherosclerosis 2009; 204: 636641.